HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

ICCVAM/ECVAM Early Collaboration Explored To Hasten Animal Alternatives

This article was originally published in The Rose Sheet

Executive Summary

Faster validation of animal alternative test methods is dependent upon increased collaboration between the Interagency Coordinating Committee for the Validation of Alternative Methods and the European Centre for the Validation of Alternative Methods, according to leaders of both groups

You may also be interested in...



ICCVAM To Study Alternative Animal Test Feasibility For Ocular Irritation

The Interagency Coordinating Committee on the Validation of Alternative Methods will review four non-animal in vitro tests this year to assess whether they are predictive in identifying severe ocular irritants and corrosives, according to the group

ICCVAM To Study Alternative Animal Test Feasibility For Ocular Irritation

The Interagency Coordinating Committee on the Validation of Alternative Methods will review four non-animal in vitro tests this year to assess whether they are predictive in identifying severe ocular irritants and corrosives, according to the group

EU Animal Testing Ban Could Conflict With FDA OTC Requirements – USTR

EU legislation banning the sale of cosmetics tested on animals could conflict with FDA testing requirements for certain products classified as OTC drugs, the United States Trade Representative states in an April 1 report estimating potential trade barriers

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

RS010820

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel